Derailing EU rules on new GMOs
CRISPR-Files expose lobbying tactics to deregulate new GMOs
29.03.2021
The biotech industry is waging a battle to get new genetic modification techniques excluded from European GMO regulations. This would mean that these new GMOs would not be subject to safety checks, monitoring or consumer labelling. Corporate Europe Observatory has uncovered precisely how the biotech developers are preparing the ground, and lobbying hard, for such deregulation.